Cargando…
Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients
BACKGROUND: Cancer immunotherapy (CIT), as a monotherapy or in combination with chemotherapy, has been shown to extend overall survival in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). However, patients experience treatment-related symptoms that they are required t...
Autores principales: | Schmalz, Oliver, Jacob, Christine, Ammann, Johannes, Liss, Blasius, Iivanainen, Sanna, Kammermann, Manuel, Koivunen, Jussi, Klein, Alexander, Popescu, Razvan Andrei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781800/ https://www.ncbi.nlm.nih.gov/pubmed/33346738 http://dx.doi.org/10.2196/18655 |
Ejemplares similares
-
Possibilities of Improving the Clinical Value of Immune Checkpoint Inhibitor Therapies in Cancer Care by Optimizing Patient Selection
por: Iivanainen, Sanna, et al.
Publicado: (2020) -
Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study
por: Kuusisalo, Saara, et al.
Publicado: (2022) -
Treatment discontinuation and re-initiation of anti-PD-(L)1 agents in metastatic cancers
por: Tikkanen, Antti, et al.
Publicado: (2020) -
Assessment of chemotherapy‐induced neurotoxicity using a point‐of‐care nerve conduction study device
por: Jokimäki, Anna, et al.
Publicado: (2022) -
Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors
por: Iivanainen, Sanna, et al.
Publicado: (2019)